title: Heparin and bone marrow-derived cell therapy: friend or foe?
authors.forename: Edward T H
authors.initials: ET
authors.lastname: Yeh
authors.forename: James T
authors.initials: JT
authors.lastname: Willerson
mesh_terms: D000818:Animals; D001854:Bone Marrow Cells / Q000166:cytology*; D064987:Cell- and Tissue-Based Therapy; D054377:Chemokine CXCL12 / Q000187:drug effects*; D005260:Female; D006493:Heparin / Q000494:pharmacology*; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000187:drug effects*; D009203:Myocardial Infarction / Q000628:therapy*; D019718:Receptors, CXCR4 / Q000187:drug effects*; D015398:Signal Transduction / Q000187:drug effects*
chemical_list: C515255:CXCL12 protein, human; C527276:CXCR4 protein, human; D054377:Chemokine CXCL12; D019718:Receptors, CXCR4; D006493:Heparin